Ad is loading...
ISPC
Price
$4.20
Change
-$0.15 (-3.45%)
Updated
Nov 15 closing price
MCRXF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
Ad is loading...

ISPC vs MCRXF

Header iconISPC vs MCRXF Comparison
Open Charts ISPC vs MCRXFBanner chart's image
iSpecimen
Price$4.20
Change-$0.15 (-3.45%)
Volume$663.35K
CapitalizationN/A
MICRO X
Price$0.04
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
ISPC vs MCRXF Comparison Chart
Loading...
ISPC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ISPC vs. MCRXF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISPC is a Sell and MCRXF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ISPC: $4.20 vs. MCRXF: $0.04)
Brand notoriety: ISPC and MCRXF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ISPC: 122% vs. MCRXF: 104%
Market capitalization -- ISPC: $2.11M vs. MCRXF: $39.55M
ISPC [@Medical Specialties] is valued at $2.11M. MCRXF’s [@Medical Specialties] market capitalization is $39.55M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ISPC’s FA Score shows that 0 FA rating(s) are green whileMCRXF’s FA Score has 0 green FA rating(s).

  • ISPC’s FA Score: 0 green, 5 red.
  • MCRXF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ISPC and MCRXF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ISPC’s TA Score shows that 2 TA indicator(s) are bullish.

  • ISPC’s TA Score: 2 bullish, 6 bearish.

Price Growth

ISPC (@Medical Specialties) experienced а -14.11% price change this week, while MCRXF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

ISPC is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCRXF($39.6M) has a higher market cap than ISPC($2.11M). MCRXF YTD gains are higher at: -53.488 vs. ISPC (-58.050). ISPC has higher annual earnings (EBITDA): -8.75M vs. MCRXF (-10.33M). MCRXF has more cash in the bank: 18.3M vs. ISPC (5.01M). ISPC has less debt than MCRXF: ISPC (196K) vs MCRXF (12.6M). MCRXF has higher revenues than ISPC: MCRXF (15.6M) vs ISPC (9.93M).
ISPCMCRXFISPC / MCRXF
Capitalization2.11M39.6M5%
EBITDA-8.75M-10.33M85%
Gain YTD-58.050-53.488109%
P/E Ratio1.05N/A-
Revenue9.93M15.6M64%
Total Cash5.01M18.3M27%
Total Debt196K12.6M2%
TECHNICAL ANALYSIS
Technical Analysis
ISPC
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
89%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
ISPC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBD23.700.04
+0.17%
Inspire Corporate Bond ETF
BTR27.03-0.39
-1.42%
Beacon Tactical Risk ETF
IZRL20.43-0.49
-2.32%
ARK Israel Innovative Technology ETF
ONT.X0.214950-0.016861
-7.27%
Ontology cryptocurrency
XTZ.X0.792759-0.080116
-9.18%
Tezos cryptocurrency

ISPC and

Correlation & Price change

A.I.dvisor tells us that ISPC and IART have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISPC and IART's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISPC
1D Price
Change %
ISPC100%
-3.45%
IART - ISPC
29%
Poorly correlated
-1.68%
STXS - ISPC
26%
Poorly correlated
-2.39%
RVTY - ISPC
26%
Poorly correlated
-5.63%
CTSO - ISPC
26%
Poorly correlated
-5.78%
RMD - ISPC
25%
Poorly correlated
+1.43%
More

MCRXF and

Correlation & Price change

A.I.dvisor tells us that MCRXF and VTAK have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCRXF and VTAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRXF
1D Price
Change %
MCRXF100%
N/A
VTAK - MCRXF
21%
Poorly correlated
-6.00%
MXCT - MCRXF
11%
Poorly correlated
-0.58%
LDXHF - MCRXF
2%
Poorly correlated
N/A
ISPC - MCRXF
1%
Poorly correlated
-3.45%
RBOT - MCRXF
0%
Poorly correlated
-11.03%
More